Michael S. Middleton

11.8k citations

103 papers · 7.6k indexed · 4 hit papers · h-index 42

Impact in

Hepatology top 0.2%
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Diseases and Immunity
Epidemiology top 0.2%
- Liver Disease Diagnosis and Treatment

Papers in

Hepatology 42
- Liver Disease and Transplantation 27
- Hepatocellular Carcinoma Treatment and Prognosis 23
Epidemiology 78
- Liver Disease Diagnosis and Treatment 78

Co-authors: Claude B. Sirlin Jeffrey B. Schwimmer Gavin Hamilton Joel E. Lavine Takeshi Yokoo Mark Bydder Rohit Loomba Tanya Wolfson
Journals: Journal of Magnetic Resonance Imaging (20 papers)Radiology (15 papers)Gastroenterology (8 papers)Journal of Hepatology (7 papers)American Journal of Roentgenology (5 papers)
Partner nations: United States Canada France

In The Last Decade

Michael S. Middleton

102 papers receiving 7.5k citations

Hit Papers

align trajectories log scale

GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease 2018 · 257 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Gastroenterology
2013 Radiology
2013 Hepatology
2010 NMR in Biomedicine

Peers

Countries citing papers authored by Michael S. Middleton

Since Specialization

Citations

This map shows the geographic impact of Michael S. Middleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Middleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Middleton more than expected).

Fields of papers citing papers by Michael S. Middleton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Middleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Middleton. The network helps show where Michael S. Middleton may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael S. Middleton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael S. Middleton Line = papers co-authored together Michael S. Middleton links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE Consortium Radiology ·Kathryn J. Fowler, Sudhakar K. Venkatesh, Nancy A. Obuchowski, Michael S. Middleton, 謙次郎庄司, Kay Pepin, Bertrand MANJOLONGO, 马志敏 MA Zhimin, J HOOFNAGLE, O. S. Lipov, Sudha S. Shankar, Tania N. Kamphaus, M. Shyaam Prakash, Roberto A. Calle, Arun J. Sanyal, Rohit Loomba, Richard L. Ehman, Anthony E. Samir, Claude B. Sirlin, Sarah P. Sherlock	2023	19
2	Association of Hepatic Steatosis with Adipose and Muscle Mass and Distribution in Children Metabolic Syndrome and Related Disorders ·Jorge Luis Medrano Anchila, Nidhi Goyal, Patricia Ugalde‐Nicalo, 一利小山, Ximin Ma, Ke-Ming Lu, Maximilian Hagspiel, Cynthia Knott, J HOOFNAGLE, O. S. Lipov, Claude B. Sirlin, Michael S. Middleton, Jeffrey B. Schwimmer	2023	2
3	Changes in abdominal adipose tissue depots assessed by MRI correlate with hepatic histologic improvement in non-alcoholic steatohepatitis Journal of Hepatology ·Wei Shen, Michael S. Middleton, Guilherme Moura Cunha, Orlando Cerrhoci, Tanya Wolfson, Anthony Gamst, Kathryn J. Fowler, Adina Alazraki, Andrew T. Trout, Michael A. Ohliger, Shetal N. Shah, Mustafa R. Bashir, David E. Kleiner, Rohit Loomba, Brent A. Neuschwander‐Tetri, Arun J. Sanyal, Jane H. Zhou, Claude B. Sirlin, Joel E. Lavine	2022	23
4	Hepatic Steatosis is Negatively Associated with Bone Mineral Density in Children The Journal of Pediatrics ·一利小山, Elizabeth L. Yu, Hortencia del Rocío Barreto Chimborazo, Craig Bross, Jeanne F. Nichols, Lynda E. Polgreen, Cynthia Knott, Alexandra Schlein, Claude B. Sirlin, Michael S. Middleton, Deborah M. Kado, Jeffrey B. Schwimmer	2021	10
5	Repeatability and accuracy of various region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification Abdominal Radiology ·Cheng William Hong, Jennifer Y. Cui, J HOOFNAGLE, Yang Xu, Tanya Wolfson, Anthony Gamst, Alexandra Schlein, Cansu Agan, Michael S. Middleton, Gavin Hamilton, Rohit Loomba, Jeffrey B. Schwimmer, Kathryn J. Fowler, Claude B. Sirlin	2021	6
6	Automated CT and MRI Liver Segmentation and Biometry Using a Generalized Convolutional Neural Network Radiology Artificial Intelligence ·Kang Wang, Adrija Mamidipalli, Tara Retson, Naeim Bahrami, Kyle Hasenstab, Kevin Blansit, Nithya Chinnusamy, М Н Михайлова, Guilherme Moura Cunha, Michael S. Middleton, Rohit Loomba, Brent A. Neuschwander‐Tetri, Claude B. Sirlin, Albert Hsiao	2019	98
7	Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease eScholarship (California Digital Library) ·Naga Chalasani, Raj Vuppalanchi, Mary E. Rinella, Michael S. Middleton, Mohammad Shadab Siddiqui, A. Sidney Barritt, Orville Kolterman, Omar Flores, Cristina Alonso, Marta Iruarrizaga‐Lejarreta, Rubén Gil‐Redondo, Claude B. Sirlin, Michael B. Zemel	2018	1
8	GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease Gastroenterology ·Rohit Loomba, Zeid Kayali, Mazen Noureddin, Peter Ruane, Eric Lawitz, Michael Bennett, Lulu Wang, Eliza Harting, Jacqueline M. Tarrant, B. Mccolgan, Chuhan Chung, Adrian S. Ray, G. Mani Subramanian, Robert P. Myers, Michael S. Middleton, Michelle Lai, Michael Charlton, Stephen A. Harrison Hit paper breakdown →	2018	257
9	Repeatability and reproducibility of 2D and 3D hepatic MR elastography with rigid and flexible drivers at end-expiration and end-inspiration in healthy volunteers Abdominal Radiology ·Kang Wang, María Andrea Fernández Bula, Nikolaus M. Szeverenyi, Tanya Wolfson, Gavin Hamilton, Michael S. Middleton, Florin Vaida, Meng Yin, Kevin J. Glaser, Richard L. Ehman, Claude B. Sirlin	2017	33
10	Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults Abdominal Imaging ·丁艳琼, Daniel Grabic, Yakir S. Levin, Jonathan Hooker, Gavin Hamilton, Tanya Wolfson, Anthony Gamst, M. Rychlik, Elhamy Heba, Rohit Loomba, Jeffrey B. Schwimmer, Michael S. Middleton, Claude B. Sirlin	2015	54
11	Accuracy of MR Imaging–estimated Proton Density Fat Fraction for Classification of Dichotomized Histologic Steatosis Grades in Nonalcoholic Fatty Liver Disease Radiology ·An Tang, Ajinkya Desai, Gavin Hamilton, Tanya Wolfson, Anthony Gamst, Jessica Lam, Lisa Clark, Jonathan Hooker, Tanya Chavez, Brandon Ang, Michael S. Middleton, Michael R. Peterson, Rohit Loomba, Claude B. Sirlin	2014	254
12	Reproducibility of MRI‐determined proton density fat fraction across two different MR scanner platforms Journal of Magnetic Resonance Imaging ·敬三細井, Irene Cruite, Masoud Shiehmorteza, Tanya Wolfson, Anthony Gamst, Gavin Hamilton, Mark Bydder, Michael S. Middleton, Claude B. Sirlin	2011	132
13	SAFETY Study: Alanine Aminotransferase Cutoff Values Are Set Too High for Reliable Detection of Pediatric Chronic Liver Disease Gastroenterology ·Jeffrey B. Schwimmer, Winston Dunn, Gregory J. Norman, Perrie E. Pardee, Michael S. Middleton, Nanda Kerkar, Claude B. Sirlin	2010	362
14	Assessment of liver fat quantification in the presence of iron Magnetic Resonance Imaging ·Mark Bydder, Masoud Shiehmorteza, Takeshi Yokoo, Wichan Chauiphan, Michael S. Middleton, Olivier M. Girard, Michael E. Schroeder, Tanya Wolfson, Anthony Gamst, Claude B. Sirlin	2010	41
15	In vivo characterization of the liver fat ¹H MR spectrum NMR in Biomedicine ·Gavin Hamilton, Takeshi Yokoo, Mark Bydder, Irene Cruite, Michael E. Schroeder, Claude B. Sirlin, Michael S. Middleton Hit paper breakdown →	2010	429
16	Capsular retraction: an uncommon imaging finding in hepatic inflammatory pseudotumour British Journal of Radiology ·Karthik Ganesan, Bárbara Viamonte, Igor Augusto Trigo, Yukihiro Kono, Cynthia Santillan, Michael S. Middleton, Claude B. Sirlin	2009	12
17	Effects of intravenous gadolinium administration and flip angle on the assessment of liver fat signal fraction with opposed‐phase and in‐phase imaging Journal of Magnetic Resonance Imaging ·Takeshi Yokoo, Julie Collins, Robert F. Hanna, Mark Bydder, Michael S. Middleton, Claude B. Sirlin	2008	20
18	Counterfactual Thinking and Quality of Life Among Women with Silicone Breast Implants Journal of Behavioral Medicine ·Patricia A. Parker, Michael S. Middleton, James A. Kulik	2002	5
19	Breast Implant Classification with MR Imaging Correlation Radiographics ·Michael S. Middleton, Michael McNamara	2000	22
20	Fat-suppression contrast-enhanced MRI in the failed back surgery syndrome: a prospective study Neuroradiology ·Bassem Georgy, John R. Hesselink, Michael S. Middleton	1995	17

About Michael S. Middleton

Michael S. Middleton is a scholar working on Hepatology, Epidemiology, Radiology, Nuclear Medicine and Imaging, Neuropsychology and Physiological Psychology and Endocrinology, Diabetes and Metabolism, having authored 103 papers that have together received 7.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (78 papers), Advanced MRI Techniques and Applications (37 papers), Liver Disease and Transplantation (27 papers), Hepatocellular Carcinoma Treatment and Prognosis (23 papers), MRI in cancer diagnosis (17 papers), Diet, Metabolism, and Disease (10 papers), Cardiovascular Disease and Adiposity (7 papers) and Breast Implant and Reconstruction (7 papers). The work is most often cited by research in Hepatology (2.9k citations), Epidemiology (5.6k citations), Endocrinology, Diabetes and Metabolism (1.8k citations), Radiology, Nuclear Medicine and Imaging (1.9k citations) and Cardiology and Cardiovascular Medicine (759 citations). Michael S. Middleton has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Claude B. Sirlin, Jeffrey B. Schwimmer, Gavin Hamilton, Joel E. Lavine, Takeshi Yokoo, Mark Bydder, Rohit Loomba, Tanya Wolfson, Anthony Gamst and Alyssa Chavez. Their work appears in journals such as Journal of Magnetic Resonance Imaging, Radiology, Gastroenterology, Journal of Hepatology and American Journal of Roentgenology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact